Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines.
Investigational New Drugs.
2023,
41(2),
210-219,
ISSN: 0167-6997,
PMID: 36913160,
PDF.
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors.
International Journal of Molecular Sciences.
2022,
23(24),
16169,
ISSN: 1422-0067,
PMID: 36555810,
PDF.